Trump Move Could Send Seniors Fleeing to Medicare Advantage
The Trump administration is ending a program early that kept Medicare prescription drug costs low, a move that experts say could push more seniors into Medicare Advantage plans.
The program, known as the Medicare Part D premium stabilization, had been holding down monthly premiums for standalone drug plans. Without it, those premiums are expected to rise sharply [206863].
Medicare Advantage plans, which combine hospital, medical, and often drug coverage in one private plan, may become a cheaper alternative for many beneficiaries [206863]. The shift could mean fewer seniors stick with traditional Medicare and a standalone Part D drug plan [206863].
The decision takes effect immediately, leaving millions of seniors facing higher drug plan costs in the coming months [206863].